Evidence map›Paper›PMID 22239520›Full record

ArticleJournal of viral hepatitis2012

The association of HIV viral load with indirect markers of liver injury.

J E Forrester, M S Rhee, B H McGovern, R K Sterling, T A Knox, N Terrin

Abstract read
In one paragraph

Article in Journal of viral hepatitis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  9. Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.Journal of acquired immune deficiency syndromes (1999) · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

J E ForresterDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA. janet.forrester@tufts.edu
M S Rhee
B H McGovern
R K Sterling
T A Knox
N Terrin
Tufts University · USGilead Sciences (United States) · USLemuel Shattuck Hospital · USTufts Medical Center · USVirginia Commonwealth University · US

Funding

TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCAUL1RR025752 · NCRR · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2008 to 2011
$17.6M
ZIDOVUDINE &LAMIVUDINE ALONE OR IN COMBINATION ON BODY COMPOSITIONM01RR000054 · NCRR · TUFTS MEDICAL CENTER · PI RAO, MADHUMATHI · 1985 to 2005
$12.2M
Nutrition and Metabolism CoreP30DA013868 · NIDA · TUFTS UNIVERSITY BOSTON · PI WANKE, CHRISTINE A · 2002 to 2012
$10.0M
NUTRITIONAL STATUS IN HIV POSITIVE HISPANIC DRUG ABUSERSR01DA011598 · NIDA · TUFTS UNIVERSITY BOSTON · PI FORRESTER, JANET E · 1999 to 2008
$5.9M
Micronutrient Metabolism in HIV+and HIV-Drug UsersR01DA014501 · NIDA · TUFTS UNIVERSITY BOSTON · PI FORRESTER, JANET E · 2002 to 2004
$1.2M
NCRR NIH HHS M01 RR000054NCRR NIH HHS UL1 RR025752NIDA NIH HHS P30 DA013868NIDA NIH HHS R01 DA011598NIDA NIH HHS R01 DA014501
6 · The paper itself

Abstract

This study assessed the association of HIV RNA with indirect markers of liver injury including FIB-4 index, liver enzymes and platelet counts in a high-risk Hispanic population. The data were derived from a prospective study that included 138 HIV/hepatitis C (HCV)-coinfected and 68 HIV-infected participants without hepatitis C or B co-infection (mono-infected). In unadjusted analyses, detectable HIV viral load (vs undetectable, <400 copies/mL) was associated with a 40% greater odds (OR 1.4, 95% CI: 1.1-1.9, P = 0.016) of FIB-4 > 1.45 in the HIV/HCV-coinfected group and 70% greater odds of FIB-4 > 1.45 (OR 1.7, 95% CI: 1.0-2.8; P = 0.046) in the HIV-mono-infected group. In multivariable analyses, a 1 log(10) increase in HIV RNA was associated with a median increase in FIB-4 of 12% in the HIV/HCV-coinfected group and 11% in the HIV-mono-infected group (P < 0.0001). Among the HIV/HCV-coinfected group, the elevating effect of HIV RNA on FIB-4 was strongest at low CD4 counts (P = 0.0037). Among the HIV-mono-infected group, the association between HIV RNA and FIB-4 was independent of CD4 cell counts. HIV RNA was associated with alterations in both liver enzymes and platelet counts. HIV antiretroviral therapy was not associated with any measure of liver injury examined. This study suggests that HIV may have direct, injurious effects on the liver and that HIV viral load should be considered when these indirect markers are used to assess liver function.

Indexed as

Viral LoadAdultEnzymesFemaleHepatitis CHispanic or LatinoHIVHIV InfectionsHumansLiverMaleMiddle AgedPlatelet CountProspective StudiesRNA, ViralEnzymesRNA, Viral

Identifiers

PMID22239520
PMCPMC3261587
OpenAlexW2095813333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.